Analysen von James Quigley
| 12.09.25 | Novartis Sell | Goldman Sachs Group Inc. | |
| 29.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 04.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 14.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 19.12.24 | Roche Sell | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 26.11.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 03.10.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 26.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 16.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 12.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 25.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 17.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 15.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 04.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 02.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 17.06.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 03.06.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.05.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.01.23 | MorphoSys Underweight | Morgan Stanley | |
| 10.08.22 | EVOTEC Underweight | Morgan Stanley | |